Therefore, this suggested that ESM1 and HIF-1α might have synergistic roles in tumor angiogenesis and cell proliferation, and they might promote CSCC progression through the VEGFα/VEGFR2/ERK signaling pathway (Figure 7). The gene discussed is HIF1A; the disease is neoplasm.